Compound Ganoderma spore Capsule

Based on the Phase II clinical trial, the effect of Compound Ganoderma Lucidum Spore Capsules on reducing the fatigue-insomnia-anorexia symptom group (chemotherapy toxicity) in patients with non-small cell lung cancer was evaluated. At the same time, the effect of Compound Ganoderma Lucidum Spore Capsules adjuvant chemotherapy on other chemotherapy toxicity, KPS score, FACT-L quality of life score, immune function, chemotherapy completion, tongue and pulse condition, MDASI-TCM symptom and degree score, body weight, and solid tumor efficacy was evaluated.